Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...

a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s exclusive ...

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from ...

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood ...

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing their ability to infiltrate solid tumours.

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody isotopes for cancer.

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...